Vertex Pharmaceuticals (VRTX) - Net earnings per share (EPS TTM)

Symbol and logo of brand vrtx.com (VRTX)

The rolling net income per share illustrates the financial dynamics of Vertex Pharmaceuticals (VRTX), where 15.49 represents the latest metric reading. Vertex Pharmaceuticals minimizes capital expenditures by outsourcing mass production to third-party contractors. Revenues are based on the sale of exclusive, high-cost medications for cystic fibrosis patients. The environmental strategy focuses on safe waste disposal and the energy efficiency of its Boston centers.

VRTX (vrtx.com) Earnings per share for the last 12 months history from 07/04/2022 to 11/15/2026

Comprehensive metric breakdowns and analytics for Vertex Pharmaceuticals Inc. (VRTX)

- share price and expert price forecast:
Stock Quotes Vertex Pharmaceuticals|VRTX - Forecast Levels Chart
- market capitalization indicators:
Market Capitalization Vertex|VRTX - Total Enterprise Value
- business book valuation details:
Book Value per Share Vertex Pharmaceuticals|VRTX - Accounting Capitalization|Market Cap to Net Assets Ratio vrtx.com|VRTX - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity Vertex Pharmaceuticals|VRTX - Long-Term Liabilities to Equity|Short-Term Debt to Capital Vertex Pharmaceuticals|VRTX - Aggregate Debt Obligations|Debts to Book Capitalization Vertex Pharmaceuticals Incorporated|VRTX - Company Long-Term Debts|Company Short-Term Debt Vertex Pharmaceuticals|Quick Liquidity vrtx.com
- net income and valuation multiples indicators:
VRTX - Net Income|Projected Future Earnings Vertex Pharmaceuticals|VRTX - P/E Multiple|Projected Price to Earnings Vertex Pharmaceuticals Inc.|VRTX - Price/Earnings to Growth Ratio|EV/EBITDA Multiple Vertex|VRTX - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Vertex Pharmaceuticals|VRTX - Earnings per share for the trailing year|Year-over-year net earnings per share growth for the last 12 months vrtx.com|VRTX - Net earnings per one share growth for the current year|Earnings growth forecast for next year Vertex Pharmaceuticals
- sales volume and revenue information:
VRTX - Company Total Revenue|Company Future Sales Volume Vertex Pharmaceuticals Inc.|VRTX - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple Vertex Corp
General company analysis:vrtx.com (VRTX)
Mass-produced product of Vertex Pharmaceuticals Incorporated

This indicator reflects the actual efficiency of earnings per share generation over a rolling year, allowing investors to assess the fundamental profitability of the business regardless of the volatility of one-time payments. By analyzing the current trailing 12-month EPS, one can see how the absolute pricing power of Vertex Pharmaceuticals (VRTX) in cystic fibrosis therapy converts into stable net income growth, shielded from market volatility.

Competitors of Vertex Pharmaceuticals (VRTX)

ALNY: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months INSM|UTHR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months BioMarin Pharma (BMRN)|BBIO (BridgeBio) - Net earnings per share (EPS TTM)|BGM: Earnings per share for the trailing year|Net earnings per share for the last 12 months COGT (Cogent Biosciences, Inc.)|XERS (Xeris Biopharma Holdings, Inc.) - Earnings per share for the trailing year|Earnings per share for the last twelve months Keros Therapeutics, Inc. KROS|ARCT (Arcturus Pharma) - Earnings per one share for the last 12 months|Eton Pharmaceuticals - Net earnings per share (EPS TTM)|Earnings per share for the trailing year KMDA (Kamada Ltd.)|FULC: Net earnings per share (EPS TTM)|Abeona (ABEO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months mereobiopharma.com|Net earnings per share for the last 12 months Protalix (PLX)|Earnings per share for the last twelve months Pliant Therapeutics Inc (PLRX)|Net earnings per share for the last 12 months Applied Therapeutics, Inc. APLT|Net earnings per share (EPS TTM) RNTX (aileronrx.com)|Net earnings per share (EPS TTM) Gelteq Limited Inc GELS|Aytu BioPharma, Inc. - Net earnings per share (EPS TTM)|chemomab.com (CMMB) - Net earnings per share for the last 12 months|SRx Health (SRXH) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Polyrizon Ltd. (PLRZ)|Net earnings per share for the last 12 months AEZS|Net earnings per share for the last 12 months Cyclo Therapeutics Inc. (CYTH)|Net earnings per share for the last 12 months INZY (inozyme.com)|RPHM - Net earnings per one share for the last twelve months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)